Environment 20 August 2020 By Liz Kalaugher Loggerhead sea turtles have been used to track water temperatures around hurricanesMichael Patrick O'Neill / Alamy Sea turtles tagged with location and temperature sensors have been used to gather data on water temperatures near hurricanes, which could help us better forecast how strong such storms will be. Hurricanes…
A health worker holds a throat swab to test Covid-19. A courier truck has been hijacked by armed robbers in Port Elizabeth and an unknown number of Covid-19 specimens are now missing. The incident comes less than a month after samples were found dumped near the N2 outside East London.National Health Laboratory Services has warned the…
By Donna Lu Bugging a room just got a little more literal with these tiny cameras that attach to beetles and capture what they seeMark Stone/University of Washington A tiny camera that hitches a ride on the backs of beetles can wirelessly livestream footage from a bug’s eye view. Shyam Gollakota and his colleagues at…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.Facing an unexpected surge in ambulance arrivals at the USNS Comfort hospital ship docked in New York City -- some running dangerously low on oxygen -- Marines on security detail ran hundreds of yards down the pier carrying fresh tanks, the Navy said…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.